🇺🇸 bisphosphonate in United States

65 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Osteonecrosis Of Jaw — 10 reports (15.38%)
  2. Fall — 7 reports (10.77%)
  3. Neuropathy Peripheral — 7 reports (10.77%)
  4. Plasma Cell Myeloma — 7 reports (10.77%)
  5. Death — 6 reports (9.23%)
  6. Pancytopenia — 6 reports (9.23%)
  7. Pneumonia — 6 reports (9.23%)
  8. Sepsis — 6 reports (9.23%)
  9. Anaemia — 5 reports (7.69%)
  10. Blood Creatinine Increased — 5 reports (7.69%)

Source database →

Other Other approved in United States

Frequently asked questions

Is bisphosphonate approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for bisphosphonate in United States?

Amgen is the originator. The local marketing authorisation holder may differ — check the official source linked above.